PXSLY ADR program terminated. FINRA deleted symbol:

https://otce.finra.org/otce/dailyList?viewType=Deletions

$PXSLY recent news/filings

bullish
bull flag

## source: finance.yahoo.com

Mon, 18 May 2015 02:03:00 GMT ~ Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate

[PR Newswire] - Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis' investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. PXS4728A is a highly selective oral small molecule inhibitor of vascular adhesion protein-1 that has shown activity in pre-clinical investigation in non-alcoholic steatohepatitis (NASH). The acquisition of this investigational anti-inflammatory drug-candidate adds a highly innovative approach to Boehringer Ingelheim's clinical development portfolio. Pharmaxis is transformed by significant deal size and recognition of its drug discovery expertise.

read full: http://finance.yahoo.com/news/boehringer-ingelheim-acquires-pharmaxis-phase-020300438.html
*********************************************************

Mon, 12 Jan 2015 15:38:04 GMT ~ 12.01.2015 - Appendix 3B - Exercise of Employee Options

[at noodls] - 12.01.2015 - Appendix 3B - Exercise of Employee Options

read full: http://www.noodls.com/view/D900CA09BF19F0CB34F9D01D85072BEA603F2422
*********************************************************

Tue, 23 Dec 2014 22:08:49 GMT ~ 23.12.2014 - PHARMAXIS ANNOUNCES SIGNIFICANT BUSINESS MILESTONES

[at noodls] - Under the terms of the commercialisation agreement Chiesi is responsible for funding up to US$22 million of the cost of the phase 3 clinical trial of Bronchitol which recently enrolled its first patient. ...

read full: http://www.noodls.com/view/05E7F9D455EEC8EAB703F6499009148D5AE10AD6
*********************************************************

Thu, 30 Oct 2014 03:42:41 GMT ~ 30.10.2014 - ASx Quarterly Cash Flow - September 2014

[at noodls] - 30.10.2014 - ASx Quarterly Cash Flow - September 2014

read full: http://www.noodls.com/view/7674754E74DF9794F15B1D03BD418CBAEF39179C
*********************************************************

Thu, 30 Oct 2014 02:43:27 GMT ~ 30.10.2014 - Quarterly Shareholder Update - September 2014

[at noodls] - 30.10.2014 - Quarterly Shareholder Update - September 2014

read full: http://www.noodls.com/view/9392EF0E9C436D01DD612035FBC9AA4AD8D0E504
*********************************************************

$PXSLY charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PXSLY company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PXSLY/company-info
Ticker: $PXSLY
OTC Market Place: OTC Pink Current
CIK code: 0001301357
Company name: Pharmaxis Ltd.
Company website: http://www.pharmaxis.com.au
Incorporated In: Australia
$PXSLY share structure

## source: otcmarkets.com

Market Value: $35,613,287 a/o Jul 22, 2015
Shares Outstanding: 228,290,300 a/o Jul 21, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$PXSLY extra dd links

Company name: Pharmaxis Ltd.
Company website: http://www.pharmaxis.com.au

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PXSLY+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PXSLY+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PXSLY+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/news - http://finance.yahoo.com/q/h?s=PXSLY+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PXSLY/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PXSLY+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PXSLY
DTCC (dtcc.com): http://search2.dtcc.com/?q=Pharmaxis+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Pharmaxis+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Pharmaxis+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.pharmaxis.com.au
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.pharmaxis.com.au#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.pharmaxis.com.au

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PXSLY
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001301357&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PXSLY&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PXSLY
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PXSLY+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PXSLY+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PXSLY
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PXSLY
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PXSLY+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PXSLY/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PXSLY+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PXSLY.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PXSLY
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PXSLY/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PXSLY/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PXSLY
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PXSLY
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PXSLY:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PXSLY
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PXSLY



$PXSLY DD Notes ~ http://www.ddnotesmaker.com/PXSLY